Loading…
Cumberland Pharmaceuticals Inc. is projected to rise to $8.39 by 2027, a +43% move from its current price of $5.86. CPIX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.62 | $5.86 | $6.11 | +0.03% |
| May 30 | $5.52 | $5.86 | $6.22 | +0.06% |
| May 31 | $5.45 | $5.87 | $6.31 | +0.09% |
| Jun 1 | $5.39 | $5.87 | $6.38 | +0.12% |
| Jun 2 | $5.34 | $5.87 | $6.45 | +0.15% |
| Jun 3 | $5.29 | $5.87 | $6.51 | +0.18% |
| Jun 4 | $5.25 | $5.87 | $6.57 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.25 | $5.87 | $6.57 | +0.21% |
| Week 2 | $5.02 | $5.88 | $6.89 | +0.42% |
| Week 3 | $4.86 | $5.90 | $7.16 | +0.63% |
| Week 4 | $4.72 | $5.91 | $7.39 | +0.84% |
| Week 5 | $4.61 | $5.92 | $7.60 | +1.05% |
| Week 6 | $4.51 | $5.93 | $7.80 | +1.26% |
| Week 7 | $4.42 | $5.95 | $7.99 | +1.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis.
It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia; Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
The stock trades at $5.87 per share and has a market cap of $87.95M. It is ranked 4308 by market capitalization among listed equities. The current price sits within a broader forecast that implies upside potential over the coming years, with the forecast showing growth in average prices from 2027 onward and substantial long-term upside in the 2040–2050 horizon.
A major floor 64.1% below — a decisive break under it would weaken the trend.
The nearest floor, 48.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.2% away) — a breakout level to watch.
A major ceiling 32.2% above — clearing it would confirm fresh momentum.
Key CPIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CPIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.71 | Buy | $5.69 | Buy |
| MA 10 | $5.43 | Buy | $5.43 | Buy |
| MA 20 | $4.93 | Buy | $5.00 | Buy |
| MA 50 | $3.91 | Buy | $4.33 | Buy |
| MA 100 | $3.97 | Buy | $3.98 | Buy |
| MA 200 | $3.52 | Buy | $3.74 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 74.03 | Sell |
| Stoch RSI (14) | 66.14 | Neutral |
| CCI (20) | 121.54 | Buy |
| Williams %R (14) | -0.63 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 25.21 | Buy |
| Bollinger %B (20,2) | 0.91 | Neutral |
| Stochastic %K (14) | 99.37 | Sell |
| TRIX (15) | 1.73 | Buy |
| Awesome (5,34) | 1.41 | Buy |
| Ultimate (7,14,28) | 69.65 | Neutral |
| Momentum (10) | 1.33 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 5.93 | Sell |
| ADX (14) | 38.74 | Buy |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is bullish, supported by a strong RSI reading. RSI14 is 80, indicating positive momentum on a 14-day scale. The price remains above the SMA50 ($3.80) and the SMA200 ($3.49).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.80 | $5.86 | $10.01 | 0% | Neutral | |
| $6.30 | $8.39 | $12.02 | +43% | Bullish | |
| $6.98 | $9.72 | $14.65 | +66% | Bullish | |
| $6.86 | $9.92 | $15.56 | +69% | Bullish | |
| $6.57 | $9.83 | $15.95 | +68% | Bullish | |
| $8.46 | $13.08 | $21.84 | +123% | Bullish | |
| $10.03 | $15.97 | $27.36 | +172% | Bullish | |
| $11.04 | $18.08 | $31.71 | +209% | Bullish | |
| $12.40 | $20.89 | $37.42 | +256% | Bullish | |
| $11.66 | $20.18 | $36.87 | +244% | Bullish | |
| $17.45 | $34.22 | $67.87 | +484% | Bullish | |
| $33.09 | $73.54 | $163.86 | +11.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.80 | $5.86 | $6.91 | +0.00% |
| June 2026 | $4.83 | $5.74 | $7.03 | -2.06% |
| July 2026 | $5.00 | $6.02 | $7.53 | +4.92% |
| August 2026 | $5.24 | $6.38 | $8.10 | +5.94% |
| September 2026 | $5.19 | $6.37 | $8.19 | -0.17% |
| October 2026 | $5.29 | $6.55 | $8.52 | +2.81% |
| November 2026 | $5.75 | $7.16 | $9.41 | +9.39% |
| December 2026 | $6.01 | $7.54 | $10.01 | +5.33% |
Click any year to see its month-by-month CPIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cumberland Pharmaceuticals Inc.'s 2026 outlook centres on $5.86, within a $2.80 to $10.01 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CPIX could reach as high as $12.02, with a base case around $8.39 and support toward $6.30 — roughly +43% from $5.86. Momentum favours further upside here.
Expect CPIX to range from $6.98 to $14.65 through 2028. The $9.72 average target implies a +66% move from current prices. That is up +16% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The CPIX price prediction for 2029 points to an average of $9.92 (low $6.86, high $15.56) — a potential gain of +69% on today's $5.86. Momentum favours further upside here.
In 2030, CPIX is projected to trade between $6.57 and $15.95, averaging $9.83 — a potential gain of +68% from today's $5.86. That is -1% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Cumberland Pharmaceuticals Inc.'s 2031 outlook centres on $13.08, within a $8.46 to $21.84 range. That is up +33% on the projected 2030 average. That marks a +123% change versus current levels. Momentum favours further upside here.
By 2032, CPIX could reach as high as $27.36, with a base case around $15.97 and support toward $10.03 — roughly +172% from $5.86. Buyers look set to stay in control over this stretch.
Expect CPIX to range from $11.04 to $31.71 through 2033. The $18.08 average target implies a +209% move from current prices. That is up +13% on the projected 2032 average. Momentum favours further upside here.
The CPIX price prediction for 2034 points to an average of $20.89 (low $12.40, high $37.42) — a potential gain of +256% on today's $5.86. Buyers look set to stay in control over this stretch.
In 2035, CPIX is projected to trade between $11.66 and $36.87, averaging $20.18 — a potential gain of +244% from today's $5.86. That is -3% versus the projected 2034 average. Momentum favours further upside here.
Cumberland Pharmaceuticals Inc.'s 2040 outlook centres on $34.22, within a $17.45 to $67.87 range. That is up +70% on the projected 2035 average. That marks a +484% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CPIX could reach as high as $163.86, with a base case around $73.54 and support toward $33.09 — roughly +11.5x from $5.86. Momentum favours further upside here.
Investing $1,000 in CPIX today (≈ 170.648464 CPIX) could be worth
$12,549.05
+$11,549.05 (+1155%) by 2050 · US Dollar
Based on the average projected CPIX price of $73.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CPIXwould be worth at today's price.
$1,000 invested in CPIX on May 27, 2025 (≈ 187.265912 CPIX) would be worth
$1,097.38
+$97.38 (+9.7%) today · 1.10× · US Dollar
Based on a CPIX entry price of $5.34 vs. today's $5.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.53 | $1,059.67 | +6.0% |
| 1 month ago | $4.19 | $1,398.57 | +39.9% |
| 3 months ago | $4.48 | $1,308.04 | +30.8% |
| 6 months ago | $2.26 | $2,592.92 | +159.3% |
| 1 year ago | $5.34 | $1,097.38 | +9.7% |
| All time (5.0y) ago | $2.87 | $2,041.81 | +104.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CPIX forecast.
Our base-case forecast reaches $12.00 around 2031.
Implied market cap at $12.00: $179.8M
The multi-year forecast shows bullish momentum with rising averages over time. By 2030, the average price is $9.86 with a max of $16.27 and an ROI of 68%. By 2040, the average price is $35.42 with a max of $71.93 and an ROI of 503.4%.
By 2050, the average price is $76.43 with a max of $175.03 and an ROI of 1202%. These projections reflect strong long-term upside but remain estimates, not guarantees, and are subject to market and company-specific risks.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $9.86, a minimum of $6.47, and a maximum of $16.27, with an ROI of 68% and a bullish sentiment.
The forecast includes bullish years (e.g., 2027–2035) with rising average prices and positive ROI (e.g., 2027 ROI 44.3%, 2028 ROI 68.1%, 2029 ROI 69.5%, 2030 ROI 68%). These are estimates and not guarantees, and investing carries risk.
Yes. The 2040 forecast shows a max of $71.93, and the 2050 forecast shows a max of $175.03, indicating prices could exceed $50 along the horizon.
Current price is $5.87 per share and market cap is $87.95M. The rank is 4308.
RSI14 is 80 with bullish sentiment. The 30-day range is $4.37 to $7.88, with resistance at $5.87 and support at $3.05; SMA50 is $3.80 and SMA200 is $3.49.
Cumberland Pharmaceuticals Inc. Community Discussion
0Share your Cumberland Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.